> Skip repeated content

Barriers to Recovery in Post Concussive Syndrome

IRB Number: 2015-809
not enrolling new patients

November 19, 2012

Institutional Review Board, Hospital for Special Surgery

The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.

For further information, see Understanding Clinical Trials/Research Studies.

Principal Investigator

Teena Shetty, MD


Niesha Voigt
Christine Villegas, MBS


A questionnaire will be sent out to Post Concussive Syndrome Patients to establish the correlation between the duration of quality rest and the recovery time following the concussion.

Inclusion/Exclusion Criteria

• Past patients of Dr. Shetty that have had concussions.
• Male and female middle school, high school, and college athletes (ages 10-25).
Exclusion :
• If age is less than 10 or greater than 25
• Unable to provide informed consent
• Inability to complete the questionnaire

Contact Information

Teena Shetty, MD
212.774. 2138